Associations between depression, resilience, and fatigue in patients with multivessel coronary disease: A cross-lag study

多支冠状动脉疾病患者的抑郁、韧性和疲劳之间的关联:一项交叉滞后研究

阅读:1

Abstract

OBJECTIVES: This study aimed to examine the associations between depression, resilience, and fatigue in patients with multivessel coronary disease and verify their causal relationships. METHODS: Between October 2023 and June 2024, 316 patients with multivessel coronary disease were recruited from three tertiary hospitals in Tangshan, China. The Patient Health Questionnaire, Connor-Davidson Resilience Scale, and the Multidimensional Fatigue Inventory were administered to the patients on the third day of admission (T1), one month after discharge (T2), and three months after discharge (T3). Pearson correlation analysis was conducted to examine the relationships among depression, resilience, and fatigue in patients with multivessel coronary disease, and cross-lagged analysis to explore the temporal causal relationships. RESULTS: In patients with multivessel coronary disease, levels of depression and fatigue decreased from T1 to T3, while resilience scores increased during the same period. The correlation analysis revealed significant relationships among depression, resilience, and fatigue at T1, T2, and T3 (P < 0.01). The autoregressive paths indicated high stability over time for depression, medium stability for resilience, and low stability for fatigue. Cross-lagged paths demonstrated that depression at T1 significantly predicted fatigue at T2 (β = 0.461, P < 0.001), and depression at T2 significantly predicted fatigue at T3 (β = 0.957, P < 0.001). And resilience at T1 significantly predicted fatigue at T2 (β = -0.271, P < 0.001), and resilience at T2 significantly predicted fatigue at T3 (β = -0.176, P < 0.001). Additionally, resilience had a moderating effect on the relationship between depression and fatigue (β = -0.760, P < 0.001). CONCLUSIONS: Our study confirmed that depression and resilience predicted fatigue in patients with multivessel coronary disease. To prevent and mitigate fatigue, alleviating depressive symptoms and enhancing resilience levels in patients at an early stage is essential.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。